Mayo Clinic Proceedings Home
MCP Digital Health Home

Asphyxiation by Laryngeal Edema in Patients With Hereditary Angioedema


      To describe the occurrence of fatal laryngeal edema in patients with hereditary angioedema due to C1 esterase inhibitor deficiency.

      Patients and Methods

      We describe 6 patients from various regions of Germany who died from laryngeal edema within the last 10 years. Furthermore, we conducted a retrospective survey of 58 patients with hereditary angioedema, originating from 46 affected families. The data were obtained from the attending physicians and from the patients' relatives.


      Among the 6 reported patients, aged 9 to 78 years, hereditary angioedema had been diagnosed in 3 and was undiagnosed in 3. None of them had an emergency cricothyrotomy or received C1 inhibitor concentrate. The interval between onset of the laryngeal edema and asphyxiation was 20 minutes in a 9-year-old boy, and in the other patients, the interval was 1 to 14 hours (mean for all, 7 hours). The retrospective survey of 58 patients with hereditary angioedema revealed 23 deaths by asphyxiation (40%). The average age of all 29 patients at the time of asphyxiation was 39 years.


      Laryngeal edema in hereditary angioedema may be fatal. Most of the patients asphyxiated between their 20th and 50th years of life, but asphyxiation can occur even in children. The possibility that the first episode of laryngeal edema may be fatal must be emphasized to the relatives, and attending physicians must have a high degree of awareness.
      C1 INH (C1 esterase inhibitor), HAE (hereditary angioedema)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Osler W
        Hereditary angio-neurolic oedema.
        Am J Med Sci. 1888; 95: 362-367
        • Donaldson VH
        • Evans RR
        A biochemical abnormality in hereditary angioncurotic edema: absence or serum inhibitor of C'1-es-terase.
        Am J Med. 1963; 35: 37-44
        • Cicardi M
        • Agostoni A
        Hereditary angioedema [editorial].
        N Engt J Med. 1996; 334: 1666-1667
        • Bork K
        • Bindewald H
        • Böckers M
        • Eckardt V
        Ascites and suspected acute abdomen in hereditary angioedema due to C1 inhibitor deficiency [in German].
        Dtsch Med Wochenschr. 1997; 122: 1347-1350
        • Munkvad S
        • Jespcrsen J
        • Gram J
        • Overgaard K
        • Ranby M
        Effects of meihylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma.
        Clin Chem. 1990; 36: 737-741
        • Nielsen EW
        • Johansen HT
        • Straume B
        • Mollnes TE
        Effect of time, temperature and additives on a functional assay of C1 inhibitor./.
        Immunol Methods. 1994; 173: 245-251
        • Spaulding WB
        Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurottc edema).
        Ann Intern Med. 1960; 53: 739-745
        • Gelfand JA
        • Sherins RJ
        • Ailing DW
        • Frank MM
        Treatment of hereditary angioedema with danazol; reversal of clinical and biochemical abnormalities.
        N Engl J Med. 1976; 295: 1444-1448
        • Agostoni A
        • Cicardi M
        Hereditary and acquired C1 inhibitor deficiency: biological and clinical characteristics in 235 patients.
        Medicine (Baltimore). 1992; 71: 206-215
        • Landemian NS
        Hereditary angioneurotic edema. L: case reports and review of the literature.
        J Allergy. 1962; 33: 316-329
        • Cicardi M
        • Bergamaschini L
        • Marasini B
        • Boccassini G
        • Tucci A
        • Agostoni A
        Hereditary angioedema: an appraisal of 104 cases.
        Am J Med Sei. 1982; 284: 2-9
        • Nielsen EW
        • Gran JT
        • Straume B
        • Mellbye OJ
        • Johanscn HT
        • Mollnes TE
        Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses.
        J Intern Med. 1996; 239: 119-130
        • Nielsen EW
        • Kjernlie DF
        • Aascth J
        Dodsfall av hereditaert angioodem.
        Tidsskr Nor Laegeforen. 1995; 115: 43-44
        • Zurlo JJ
        • Frank MM
        The long-term safety of danazol in women with hereditary angiocdema.
        Fertil Steril. 1990; 54: 64-72
        • Cicardi M
        • Bergamaschini L
        • Cugno M
        • Hack E
        • Agostoni G
        • Agostoni A
        Long-term treatment of hereditary angioedema with altenuated androgens: a survey of a 13-year experience.
        J Allergy Clin Immunol. 1991; 87: 768-773
        • Bork K
        • Pitton M
        • Harten P
        • Koch P
        Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema [letier].
        Lancet. 1999; 353: 1066-1067
        • Crampon D
        • Barnoud R
        • Durand M
        • et al.
        Danazol therapy: an unusual aetiology of hepatocellular carcinoma [letter].
        J Hepatol. 1998; 29: 1035-1036
        • Gadek JE
        • Hosea SW
        • Gelfand JA
        • et al.
        Replacement therapy in hereditary angioedema; successful treatment of acute episodes of angioedema with partly purified C1 inhibitor.
        N Engl J Med. 1980; 302: 542-546
        • Waytes AT
        • Rosen FS
        • Frank MM
        Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate.
        N Engl J Med. 1996; 334: 1630-1634
        • Kunschak M
        • Engl W
        • Maritsch F
        • et al.
        A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema.
        Transfusion. 1998; 38: 540-549
        • Bork K
        • Witzke G
        Long-term prophylaxis with Cl-inhibitor (Cl-INH) concentrate in patients with recurrent angiocdema caused by hereditary and acquired C1-inhibitor deficiency.
        J Allergy Clin Immunol. 1989; 83: 677-682
        • Cicardi M
        • Castelli R
        • Zingale LC
        • Agostoni A
        Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients.
        J Allergy Clin Immunol. 1997; 99: 194-196
        • Jensen NF
        • Weiler JM
        C1 esterase inhibitor deficiency, airway compromise, and anesthesia.
        Anesth Analg. 1998; 87: 480-488
        • Pruet CW
        • Kornblut AD
        • Brickman C
        • Kaliner MA
        • Frank MM
        Management of the airway in patients wnh angioedema.
        Laryngoscope. 1983; 93: 749-755